Jacqueline Smith - PetMed Express VP People
| PQM Stock | EUR 4.37 0.17 4.05% |
Insider
Jacqueline Smith is VP People of PetMed Express
| Phone | 561 526 4444 |
| Web | https://www.1800petmeds.com |
Jacqueline Smith Latest Insider Activity
Tracking and analyzing the buying and selling activities of Jacqueline Smith against PetMed Express stock is an integral part of due diligence when investing in PetMed Express. Jacqueline Smith insider activity provides valuable insight into whether PetMed Express is net buyers or sellers over its current business cycle. Note, PetMed Express insiders must abide by specific rules, including filing SEC forms every time they buy or sell PetMed Express'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Jacqueline Smith over three months ago Disposition of 601 shares by Jacqueline Smith of PetMed Express at 3.19 subject to Rule 16b-3 | ||
Jacqueline Smith over a year ago Acquisition by Jacqueline Smith of 7350 shares of PetMed Express subject to Rule 16b-3 |
PetMed Express Management Efficiency
The company has return on total asset (ROA) of 0.0524 % which means that it generated a profit of $0.0524 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0831 %, meaning that it generated $0.0831 on every $100 dollars invested by stockholders. PetMed Express' management efficiency ratios could be used to measure how well PetMed Express manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Petter LLM | Oriola Oyj | 47 | |
| Joy Seusing | Rite Aid | N/A | |
| Trent Kruse | Rite Aid | N/A | |
| Zheng Shen | Beijing Tong Ren | 49 | |
| Elina Niemela | Oriola Oyj | 45 | |
| Hannes Hasselrot | Oriola Oyj | 43 | |
| Fei Chen | Beijing Tong Ren | 52 | |
| Katarina MSc | Oriola Oyj | 54 | |
| Chris Bohrer | Rite Aid | N/A | |
| Marcy Syms | Rite Aid | 67 | |
| Elisa MSc | Oriola Oyj | 57 | |
| Petri MSc | Oriola Oyj | 57 | |
| Brian Hoover | Rite Aid | 58 | |
| Tikanoja MSc | Oriola Oyj | 53 | |
| Heyward BA | Rite Aid | 62 | |
| Andre Persaud | Rite Aid | N/A | |
| Erik Keptner | Rite Aid | N/A | |
| Paul Gilbert | Rite Aid | 56 | |
| Robert Knowling | Rite Aid | 64 | |
| Bari Harlam | Rite Aid | 58 | |
| Fredrik Pamp | Oriola Oyj | N/A | |
Management Performance
| Return On Equity | 0.0831 | |||
| Return On Asset | 0.0524 |
PetMed Express Leadership Team
Elected by the shareholders, the PetMed Express' board of directors comprises two types of representatives: PetMed Express inside directors who are chosen from within the company, and outside directors, selected externally and held independent of PetMed. The board's role is to monitor PetMed Express' management team and ensure that shareholders' interests are well served. PetMed Express' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, PetMed Express' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Mark Moseley, Chief Officer | ||
| Daniel Pingree, Chief Officer | ||
| Matthew Hulett, Pres CEO | ||
| Christine Chambers, Principal CFO | ||
| Jacqueline Smith, VP People | ||
| Bruce Rosenbloom, Treasurer | ||
| Wendy Zalai, Corp Sec |
PetMed Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is PetMed Express a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0831 | |||
| Return On Asset | 0.0524 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 0.05 % | |||
| Current Valuation | 290.33 M | |||
| Shares Outstanding | 21.08 M | |||
| Shares Owned By Insiders | 4.29 % | |||
| Shares Owned By Institutions | 82.51 % | |||
| Price To Earning | 9.60 X | |||
| Price To Book | 2.78 X |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in PetMed Stock
When determining whether PetMed Express is a strong investment it is important to analyze PetMed Express' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact PetMed Express' future performance. For an informed investment choice regarding PetMed Stock, refer to the following important reports:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PetMed Express. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in PetMed Stock please use our How to Invest in PetMed Express guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.